Literature DB >> 15385543

Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure.

Sagartirtha Sarkar1, Mamta Chawla-Sarkar, David Young, Kazutoshi Nishiyama, Mary E Rayborn, Joe G Hollyfield, Subha Sen.   

Abstract

Cardiac hypertrophy and ensuing heart failure are among the most common causes of mortality worldwide, yet the triggering mechanisms for progression of hypertrophy to failure are not fully understood. Tissue homeostasis depends on proper relationships between cell proliferation, differentiation, and death and any imbalance between them results in compromised cardiac function. Recently, we developed a transgenic (Tg) mouse model that overexpress myotrophin (a 12-kDa protein that stimulates myocyte growth) in heart resulting in hypertrophy that progresses to heart failure. This provided us an appropriate model to study the disease process at any point from initiation of hypertrophy end-stage heart failure. We studied detailed apoptotic signaling and regenerative pathways and found that the Tg mouse heart undergoes myocyte loss and regeneration, but only at a late stage (during transition to heart failure). Several apoptotic genes were up-regulated in 9-month-old Tg hearts compared with age-matched wild type or 4-week-old Tg hearts. Cardiac cell death during heart failure involved activation of Fas, tumor necrosis factor-alpha, and caspases 9, 8, and 3 and poly(ADP-ribose) polymerase cleavage. Tg mice with hypertrophy associated with compromised function showed significant up-regulation of cyclins,cyclin-dependent kinases (Cdks), and cell regeneration markers in myocytes. Furthermore, in human failing and nonfailing hearts, similar observations were documented including induction of active caspase 3 and Ki-67 proteins in dilated cardiomyopathic myocytes. Taken together, our data suggest that the stress of extensive myocardial damage from longstanding hypertrophy may cause myocytes to reenter the cell cycle. We demonstrate, for the first time in an animal model, that cell death and regeneration occur simultaneously in myocytes during end-stage heart failure, a phenomenon not observed at the onset of the disease process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385543     DOI: 10.1074/jbc.M402037200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Harnessing fetal and adult genetic reprograming for therapy of heart disease.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  J Nat Sci       Date:  2015-04

2.  Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy.

Authors:  Aina He; Wenqian Fang; Kun Zhao; Yajun Wang; Jie Li; Chongzhe Yang; Feriel Benadjaoud; Guo-Ping Shi
Journal:  Transl Res       Date:  2019-01-19       Impact factor: 7.012

3.  Inhibition of signal transducer and activator of transcription 3 (STAT3) attenuates interleukin-6 (IL-6)-induced collagen synthesis and resultant hypertrophy in rat heart.

Authors:  Saiful Anam Mir; Arunachal Chatterjee; Arkadeep Mitra; Kanchan Pathak; Sushil K Mahata; Sagartirtha Sarkar
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

4.  Lack of beta3 integrin signaling contributes to calpain-mediated myocardial cell loss in pressure-overloaded myocardium.

Authors:  Geetha Suryakumar; Harinath Kasiganesan; Sundaravadivel Balasubramanian; Dhandapani Kuppuswamy
Journal:  J Cardiovasc Pharmacol       Date:  2010-06       Impact factor: 3.105

Review 5.  Small mammalian animal models of heart disease.

Authors:  Paula Camacho; Huimin Fan; Zhongmin Liu; Jia-Qiang He
Journal:  Am J Cardiovasc Dis       Date:  2016-09-15

6.  Beta3 integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy.

Authors:  Rebecca K Johnston; Sundaravadivel Balasubramanian; Harinath Kasiganesan; Catalin F Baicu; Michael R Zile; Dhandapani Kuppuswamy
Journal:  FASEB J       Date:  2009-04-13       Impact factor: 5.191

Review 7.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

8.  Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.

Authors:  Peng Xia; Yuening Liu; Jingrui Chen; Shelby Coates; David X Liu; Zhaokang Cheng
Journal:  J Biol Chem       Date:  2018-10-25       Impact factor: 5.157

9.  Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure.

Authors:  Biswajit Das; David Young; Amit Vasanji; Sudhiranjan Gupta; Sagartirtha Sarkar; Subha Sen
Journal:  Cardiovasc Res       Date:  2010-03-03       Impact factor: 10.787

10.  Role of α-crystallin B as a regulatory switch in modulating cardiomyocyte apoptosis by mitochondria or endoplasmic reticulum during cardiac hypertrophy and myocardial infarction.

Authors:  A Mitra; T Basak; K Datta; S Naskar; S Sengupta; S Sarkar
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.